SPY771.54+0.02%QQQ744.95+0.06%BTC/USD83,717.00−0.79%DIA517.45−0.01%GLD392.95−0.12%TLT79.30−0.03%
Benzinga

ACADIA Pharmaceuticals Inc (ACAD) Stock Price, Quote, News & History

ACADNASDAQ
Trade with Public
Trade with Public
$20.68
-1.50-6.76%
At close: Sep 25, 5:00 PM EST
$20.75
0.070.34%
After Hours: 4:53 PM EST
PRO
Why Is It Moving?™:ACADIA Pharmaceuticals shares are trading lower after multiple analyst firm...
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

ACADIA Pharmaceuticals (ACAD) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$22.21
Close
$20.68
Volume / Avg.
3.36M / 1.77M
Day Range
$20.61 - $22.21
52 Wk Range
19.69 - 30.96
Market Cap
$3.55B
P/E Ratio
9.95
Dividend Yield
-
Exchange
NASDAQ
RSI
17
Short Interest
8.96%
Days to Cover
7.22

Recent Acadia Pharmaceuticals Inc. News

AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday

Analysts cut targets for GWW, IE and COST, while raising targets for OKTA, AXGN, ZS and DRI; ratings remained unchanged.
Avi Kapoor

Acadia Drug Misses Primary Goal in Alzheimer’s Related Psychosis

Acadia Pharmaceuticals reports Phase 2 remlifanserin trial results for Alzheimer’s psychosis and plans to move into Phase 3.
Vandana Singh

Crude Oil Rises Over 4%; Darden Earnings Miss Views

U.S. stocks fell Thursday: Dow -0.7%, S&P 500 -0.46%, Nasdaq -0.7%. Oil jumped 4.4%; Darden missed estimates, while APUS surged 163%.
Avi Kapoor

Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change outlook on top names. See all rating changes, including upgrades and downgrades, on analyst ratings page.
Avi Kapoor

Acadia Pharma Stock Jumps After European Panel Reverses Course On Rett Syndrome Therapy

Acadia shares rise after CHMP recommends DAYBU for Rett syndrome in the European Union, reversing an earlier negative opinion.
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
160.32M
Investing Cash Flow (TTM)
-77.47M
Financing Cash Flow (TTM)
46.81M
Free Cash Flow (TTM)
145.63M
Capital Expenditure (TTM)
-14.69M
Net Change in Cash (TTM)
129.66M

Analyst Trends and Forecast

2
May
3
Jun
2
Jul
6
1
Aug
6
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.94B
PE Ratio (TTM)
9.95
PE Ratio (FWD)
21.98
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.36
PB Ratio (TTM)
2.92
Earnings Yield % (TTM)
10.05%
Earnings Yield % (FWD)
4.55%
EV / EBITDA (TTM)
29.87
Price / EBITDA (TTM)
38.83
Price / Free Cash Flow (TTM)
26.24
Book Value / Share
$7.58

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$384.99M
Debt to Equity
0.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$22.21
Close
$20.68
Volume / Avg.
3.36M / 1.77M
Day Range
$20.61 - $22.21
52 Wk Range
19.69 - 30.96
Market Cap
$3.55B
P/E Ratio
9.95
Dividend Yield
-
Exchange
NASDAQ
RSI
17
Short Interest
8.96%
Days to Cover
7.22

About

Sector
Health Care
Industry
Biotechnology
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare dise...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ACADIA Pharmaceuticals (ACAD) stock?

A

You can purchase shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ACADIA Pharmaceuticals (ACAD) competitors?

Q

What is the forecast, or price target, for ACADIA Pharmaceuticals (ACAD) stock?

A

ACADIA Pharmaceuticals has a consensus price target of $30.82.

Q

What is the current price for ACADIA Pharmaceuticals (ACAD)?

A

The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $20.75 last updated September 25, 2026 at 4:53 PM EDT.

Q

Does ACADIA Pharmaceuticals (ACAD) pay a dividend?

A

There are no upcoming dividends for ACADIA Pharmaceuticals.

Q

When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?

A

ACADIA Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is ACADIA Pharmaceuticals (ACAD) going to split?

A

There is no upcoming split for ACADIA Pharmaceuticals.

Q

What sector and industry does ACADIA Pharmaceuticals (ACAD) operate in?

A

ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved